DNMT3A and breast carcinoma: They down-regulated Maspin and SOX2 expression in SUM159 and MCF-7 breast cancer cell lines using a synthetic epigenetic construct of six ZF domain (6ZF) array linked to the DNMT3a catalytic domain (6ZF-DNMT3a).